Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.
-
Research
- Experts
In The News
View AllDr. Williams Interviewed by Healthcare IT News
Regenstrief Research Scientist Linda S. Williams, M.D., addressed how teleneurology...
Influence
View AllRegenstrief researcher named chair of quality committee of one of nation’s largest medical professional organizations
A national leader in improving the quality of healthcare provided...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
Influence
February 13, 2020
Regenstrief researchers leading core of national research incubator

Related News
News
September 21, 2023
Supportive later-life social relationships mediate the risk of severe frailty in adults who had negative childhood experiences
Frailty is a serious concern in later-life adults due to its association with additional health risks including disability, falls,
Video
September 19, 2023
Dr. Dixon describes CDC findings on those who face highest risk from COVID-19
News
September 19, 2023
COVID-infected adults with 4 or more underlying diseases or advanced age face higher risk of ICU stay, death
10-state June 2021-March 2023 study from CDC’s VISION Network identifies risk factors for critical outcomes Whether vaccinated or not,